Smokers have lower odds of surviving a heart attack than non-smokers

Smokers have a lower chance of surviving a heart attack than non-smokers, according to new data compiled by researchers at Jordan University of Science and Technology in Irbid. Levels of Alpha-1 Anti Trypsin (A1AT)-; a protein in the liver that protects the body's tissues-; in smokers were "significantly less" than in non-smokers, the study found. Yet, no difference was detected in hypertensive and non-hypertensive individuals. The researchers will present their findings in person at the American Physiological Society's (APS) annual meeting at Experimental Biology 2022 in Philadelphia.

Approximately 1.5 million heart attacks and strokes happen annually in the U.S., according to the U.S. Department of Health and Human Services' Division for Heart Disease and Stroke Prevention. It is believed A1AT could offer protection to cardiac tissue when it is released during a heart attack.

The aim of this study was to compare the plasma levels of A1AT released in smokers and non-smokers, and between hypertensive and non-hypertensive individuals after an attack."

Said Khatib, PhD, co-author of the study

The human study was conducted in 29 adult men and 11 adult women through blood samples drawn within one, four, 24, 48 and 96 hours of a heart attack diagnosis. Participants were divided into four groups of smokers and non-smokers, and hypertensive and non-hypertensive.

Researchers believe that maintaining appropriate levels of A1AT in smokers during a heart attack will improve their chances of survival.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study identifies potential target for treating diabetic cardiomyopathy